Vikas Dua: Heme Next 1.0 A Conference with a Difference
Vikas Dua, Principal Director and Head of Pediatric Hematology, Oncology and Bone Marrow Transplant at Fortis Memorial Research Institute Gurugram, shared on LinkedIn:
”Heme Next 1.0 A Conference with a Difference
Over the past weekend, we witnessed something truly special at Heme Next 1.0 a meeting that reimagined what a scientific conference can look like.
From the moment our humanoid host HemeBot took the stage, it was clear this wasn’t going to be just another academic gathering. We set out to showcase the future of hematology, oncology, and BMT and I’m proud that we delivered exactly that.
What inspired me the most was seeing the next generation of pediatric hematology and oncology come together with unmatched energy. Experts from across India, and even Singapore, shared cutting-edge insights on:
- Next-gen treatment strategies in pediatric and adult cancers
- CAR-T cell therapy updates
- Advances in genomics and precision diagnostics
- AI-driven decision support and clinical workflows
- Infectious disease innovations relevant to our field
The academic spirit was at its peak during the Intel Ignite Quiz, which saw enthusiastic participation from residents nationwide. Their curiosity, competitiveness, and brilliance made it a highlight of the event.
The brainstorming sessions were rich, bold, and forward-looking exactly what our specialty needs as we step into an era of transformative therapies.
Proud of our community. Proud of our vision. Proud of the future we are building for every child fighting cancer.
Thank you Dr Rahul Bhargava for the shared vision which envisaged in a way we never imagined.”
Keep up with Hemostasis Today.
-
Jun 11, 2026, 07:41Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide
-
Jun 11, 2026, 07:06Bernard Slater Jr.: Hemophilia B Reminds You that No Matter How Strong You Are, You Are Still Human
-
Jun 11, 2026, 05:11Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
-
Jun 11, 2026, 05:03Aymeric Couturier: Lessons from the TRACK Trial on Anticoagulation in Advanced CKD
-
Jun 11, 2026, 04:53Umut Kocabas: Current Practice and Guideline Adherence on Cancer-Associated Thrombosis in Turkey
-
Jun 11, 2026, 04:40Fernanda Orsi: Which Obstetric APS Patients Are More Likely to Develop Thromboses?
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See